Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Cytosorbents Corp market cap for the quarter ending 2026-07-31 was $22.96M, a 58.57% decline year-over-year.
Cytosorbents Corp market cap for the quarter ending 2026-06-30 was $23.57M, a 70.59% decline year-over-year.
Cytosorbents Corp market cap for the quarter ending 2026-05-07 was $37.9M, a 31.22% decline year-over-year.
Cytosorbents Corp market cap for the quarter ending 2026-03-31 was $35.76M, a 42.81% decline year-over-year.
Cytosorbents Corp market cap for fiscal 2026 was $22.96M.
Cytosorbents Corp market cap for fiscal 2025 was $40.3M, a 19.23% decline from fiscal 2024.
Cytosorbents Corp market cap for fiscal 2024 was $49.9M, a 17.13% decline from fiscal 2023.
Cytosorbents Corp market cap for fiscal 2023 was $60.21M, a 10.98% decline from fiscal 2022.